Bill

Bill > HB830


VA HB830

VA HB830
Pharmacy benefits managers; requirements, scope, report.


summary

Introduced
01/13/2026
In Committee
02/18/2026
Crossed Over
02/16/2026
Passed
Dead

Introduced Session

2026 Regular Regular Session

Bill Summary

Pharmacy benefits managers; requirements; scope; report. Requires a pharmacy benefits manager to use the pass-through pricing model and prohibits a pharmacy benefits manager from deriving income from pharmacy benefits management services provided to a carrier except for income derived from a pharmacy benefits management fee. The bill prohibits a pharmacy benefits manager from (i) reversing and or resubmitting the claim of a pharmacist or pharmacy without meeting certain requirements, (ii) reducing any payment to a pharmacist or pharmacy to an effective rate of reimbursement, or (iii) retroactively denying or reducing a claim or aggregate of claims except under certain circumstances. The bill applies all of the requirements for pharmacy benefits managers to the state employee health plan and certain reporting requirements to the state pharmacy benefits manager. The bill requires the State Corporation Commission (the Commission) to annually prepare a report based on certain information that examines the overall impact of prescription drug costs on health care premiums in the Commonwealth. Additionally, the bill requires the Commission to examine the practice of carriers or pharmacy benefits managers requiring or inducing covered individuals to utilize pharmacy services at an affiliated pharmacy. The Commission is required to report its findings and recommendations to the General Assembly by December 1, 2026.

AI Summary

This bill mandates that pharmacy benefit managers (PBMs), which are companies that manage prescription drug benefits on behalf of health insurers or employers, must adopt a "pass-through pricing model," meaning they can only earn income from fees for their services and cannot profit from the difference between what they pay pharmacies and what they charge health plans. It also prohibits PBMs from unfairly reversing or resubmitting pharmacy claims, reducing payments to pharmacies to an unreasonably low rate, or retroactively denying or reducing payments except under specific circumstances like fraud or if services weren't rendered. These requirements are extended to the state employee health plan, and the State Corporation Commission (the Commission) is tasked with producing an annual report on the impact of prescription drug costs on healthcare premiums and investigating whether health plans or PBMs unfairly steer individuals towards affiliated pharmacies, with findings and recommendations due to the General Assembly by December 1, 2026.

Committee Categories

Budget and Finance, Business and Industry

Sponsors (31)

Last Action

Referred to Committee on Commerce and Labor (on 02/18/2026)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...